Premium Essay

Hmj- Johnson & Johnson Final Report

In:

Submitted By hjanjua
Words 14460
Pages 58
04/26/2013
Healthcare

Johnson & Johnson
Ticker: JNJ

Recommendation: Buy

Company
Current Price: $84.83

Implied Price: $93.03

Investment Thesis
Key Statistics

Logo

50-Day Moving Average

Johnson & Johnson is one of America’s largest companies, and it has a massive assortment of consumer brand holdings which will provide it with consistent growth.



The company is growing through acquisitions that allow them to capture more market share, particularly in markets outside the United States.



52 Week Price Range



Johnson & Johnson is a stable company that has been increasing returns to shareholders through dividend increases and stock repurchases.

61.71-84.93
$80.44

Estimated Beta

.55

Dividend Yield

3%

Market Capitalization
3-Year Revenue CAGR

4.74%

Five-Year Stock Chart

231.5B
$90.00

120,000,000

$80.00
100,000,000
$70.00

Trading Statistics

$60.00

Diluted Shares Outstanding

2.90 Billion

80,000,000

$50.00
60,000,000

Average Volume (3-Month)

9.87 Million

$40.00
$30.00

Institutional Ownership

68.00%

40,000,000

$20.00
20,000,000
$10.00

Insider Ownership

0.03%
$0.00
Apr-08 Oct-08 Apr-09 Oct-09 Apr-10 Oct-10 Apr-11

EV/EBITDA (LTM)

12.66

Volume

Adjusted Close

0
Oct-11

50-Day Avg

Apr-12

Oct-12

200-Day Avg

Forecast Summary

Margins and Ratios

EBITDA Margin (LTM)

27.63%

03/31/2014E

06/30/2014E

09/30/2014E

12/31/2014E

2014E

$70,720

$17,754

$18,199

$18,764

$19,507

$74,224

EBITDA ($M)

$20,367

$5,166

$5,569

$5,648

$5,275

$21,658

Basic EPS ($)

67.78%

2013E

Net Sales ($M)

Gross Margin (LTM)

UOIG Projections

4.11

1.00

1.10

1.10

1.18

4.39

$71,000
$23,500
5.35

$18,638
$6,250
1.34

$18,638
$6,250
1.34

$18,638

Similar Documents